찰스 리버 래버러토리즈(CRL)는 NYSE에 상장된 Healthcare · Diagnostics & Research 기업입니다. 현재가 $278.06 (-1.28%), 시가총액 $7.84B, 52주 최저~최고 $134.98 ~ $226.77.
Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. The Research Models and Services segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including genetically engineered models and services, insourcing solutions, and research animal diagnostic services; and engages in development and production of cell therapies. The Discovery and Safety Asse
찰스 리버 래버러토리즈의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.
찰스 리버 래버러토리즈의 현재 주가는 $278.06 (-1.28%)입니다. BlackAll Trade에서 실시간 시세와 차트를 확인할 수 있습니다.
찰스 리버 래버러토리즈의 시가총액은 약 $7.84B입니다.
Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationall